Search
-
Luye Pharma Files New Drug Application for Lurbinectedin in Hong Kong
Hong Kong, China, March 4, 2022 — Luye Pharma Group today announced that it has filed a New Drug Application (NDA) in Hong Kong, China for Lurbinectedin, for the treatment of adult patients with meta...
2022-03-08
MORE>
-
Luye Pharma and Biostar Enter into a Partnership for Marketing Innovative Anticancer Drug Utidelone in Chinese Mainland
Luye Pharma Group has announced a partnership between its wholly-owned subsidiary Yantai Luye Drugs Trading Co. Ltd. and Chengdu Biostar Pharmaceuticals Co., Ltd., a wholly-owned subsidiary of Beijing...
2022-02-22
MORE>
-
Marketing Authorization Application for Luye Pharma's Innovative Anticancer Formulation Goserelin Microspheres Accepted in China
Luye Pharma Group announced on December 29 that the marketing authorization application for Goserelin Acetate Extended-release Microspheres for Injection (LY01005), an innovative formulation for the t...
2021-12-30
MORE>
-
Luye Pharma Releases Top-Line Results from a Phase II Clinical Trial of Its New Antidepressant Ansofaxine Hydrochloride Extended-Release Tablets
Luye Pharma Group today released the encouraging top-line results from a Phase II clinical trial of its new antidepressant, Ansofaxine Hydrochloride Extended-Release Tablets (LY03005), at the 19th Nat...
2021-12-23
MORE>
-
Luye Pharma Grants Gensci Exclusive Commercialization Rights of Rivastigmine Transdermal Patches on China’s Mainland
Luye Pharma will receive an upfront payment of RMB 70 million, and the total payment of this agreement is up to RMB 216 million.Gensci will include Rivastigmine Single-Day Transdermal Patches and Riva...
2021-12-23
MORE>
-
Luye Pharma’s Rykindo® (Risperidone Microspheres for Injection (II)) Included in the 2021 Chinese National Reimbursement Drug List
Luye Pharma Group today announced that Rykindo® (Risperidone Microspheres for Injection (II)), its new anti-schizophrenia drug, has been put on the latest edition of the National Reimbursement Drug Li...
2021-12-03
MORE>
-
ViroKey® SARS-CoV-2 RT-PCR Test v2.0 detects SARS-CoV-2 variants
The spread of SARs-CoV-2 variant Omicron has raised global attention recently. Vela Diagnostics, a subsidiary company under Luye Life Sciences Group that focuses on molecular diagnostics, has evaluate...
2021-12-02
MORE>
-
Luye Life Sciences Group Receives Two Awards Including “2021 Most Influential Brand of Social Responsibility”
On November 29, 2021, 2021 (4th) Social Responsibility Conference was held in Shanghai. Luye Life Sciences Group was awarded “2021 Most Influential Brand of Social Responsibility” and “Sustainable ...
2021-11-30
MORE>
-
Boan Biotech Reaches Strategic Collaboration Agreement with Merck to Build Its “Digital Factory of the Future”
Boan Biotech, a subsidiary of Luye Pharma Group, announced today that it has signed a Memorandum of Understanding with Merck, a world-leading science and technology company, under which the two partie...
2021-11-25
MORE>
-
Mindfront Health Opens New Outpatient Center in Shanghai to Provide World-Class Mental Health Services
18 November 2021, Shanghai - Mindfront Health, the global mental service brand of Luye Medical Group opened a new outpatient center in Crystal Galleria, Jing’an CBD, Shanghai, China. Supported b...
2021-11-19
MORE>
var _hmt = _hmt || [];
(function() {
var hm = document.createElement("script");
hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864";
var s = document.getElementsByTagName("script")[0];
s.parentNode.insertBefore(hm, s);
})();
!function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7iMpaU8NS42Fm",ck:"K9y7iMpaU8NS42Fm"});
one体育-艾尚体育
沐鸣平台_沐鸣平台科技_沐鸣平台厂家_沐鸣平台企业
力量体育app_官网-力量体育app
one体育-官网app下载
im电竞官网app